124 results
Page 2 of 7
8-K/A
EX-99.3
nz3egpnna pgwns
4 Oct 22
Other Events
4:42pm
8-K
EX-99.1
r3bd6x bvonxdzfxg44i
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
425
col1x
15 Aug 22
Business combination disclosure
6:46am
8-K
EX-99.3
71tcnfc852l4c5j i1
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.2
f3wu9ic2eh3
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
5af xho18h5x7uw
29 Jul 22
Prospectus supplement
4:06pm
425
3mz3z
6 Jul 22
Business combination disclosure
4:05pm
425
ufo2ufi64 dpvb
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.2
y4mc6kqv4
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
olam2ivhbawsj fj
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
425
89ww6jqm4
27 Apr 22
Business combination disclosure
5:26pm
8-K
EX-99.2
xrq 9on04
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
0izjcrtvg kphlv6pxi8
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
weksmxrf1w0s 8i9z8
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm